Reversal of left ventricular hypertrophy (LVH) in hypertensive patients appears to be a desirable goal to the reduction cardiac risk. The Renin-Angiotensin System (RAS) seems to play a major role in the establishment and maintenance of LVH through the activated systemic RAS and the Intracardiac Angiotensin System (IAS). We focused on the effects of a three-year treatment with losartan supplement in hypertensive patients with LVH not responding to eight years of an effective previous antihypertensive pharmacological treatment.

Effects of losartan on left ventricular mass. a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment / Moroni, Carlo; Tolone, S; Lopreiato, F; Scrofani, A. R; Bossini, A; Affricano, C; Cassone, Rosario; Gaudio, Carlo. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 2284-0729. - STAMPA. - 21:6(2017), pp. 1323-1328.

Effects of losartan on left ventricular mass. a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment

MORONI, Carlo
;
CASSONE, Rosario;GAUDIO, Carlo
2017

Abstract

Reversal of left ventricular hypertrophy (LVH) in hypertensive patients appears to be a desirable goal to the reduction cardiac risk. The Renin-Angiotensin System (RAS) seems to play a major role in the establishment and maintenance of LVH through the activated systemic RAS and the Intracardiac Angiotensin System (IAS). We focused on the effects of a three-year treatment with losartan supplement in hypertensive patients with LVH not responding to eight years of an effective previous antihypertensive pharmacological treatment.
2017
losartan; myocardial hypertrophy; follow-up; elderly
01 Pubblicazione su rivista::01l Trial clinico
Effects of losartan on left ventricular mass. a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment / Moroni, Carlo; Tolone, S; Lopreiato, F; Scrofani, A. R; Bossini, A; Affricano, C; Cassone, Rosario; Gaudio, Carlo. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 2284-0729. - STAMPA. - 21:6(2017), pp. 1323-1328.
File allegati a questo prodotto
File Dimensione Formato  
Moroni_Effects_2017.pdf

solo gestori archivio

Note: ARTICOLO PRINCIPALE
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 622.69 kB
Formato Adobe PDF
622.69 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/968012
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact